Nina Kjellson
General Partner at Canaan Partners
Sausalito, California
Overview
Work Experience
Board Member
2024 - Current
Board Member
2024
Medical science is poised like never before to crack the code to some of humankind’s most vexing health challenges
Board Member
2023
Actio Biosciences is a research center that develops drugs for rare diseases.
Raised $55,000,000.00 from Canaan Partners, Euclidean Capital, Droia Ventures, EcoR1 Capital and Deerfield Management.
General Partner
2015
Venture capital investing. New company formation. Partnering with entrepreneurs.
Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.
Board Member
2023
Proxygen is focused on the discovery and development of molecular glue degraders against targets of unmet medical need across various indications. While advancing its internal programs towards clinical development, the company also maintains strategic partnerships to co-create synergies along the drug development pipeline. With its headquarters and laboratory operations in Vienna, Austria, Proxygen employs talent both locally and remotely all over Europe. Partnered with Boehringer Ingelheim and Merck KGaA.
Board Member
2022
Rondo Therapeutics is a biopharmaceutical company exploring new frontiers in cancer therapy. Rondo is committed to advancing the field of immuno-oncology, with a focus on treating solid tumors that fail to respond to current therapies. Our solution is to create a new class of bispecific antibodies that safely engage the immune system to initiate and sustain a robust anti-tumor response and overcome the suppressive tumor microenvironment.
Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.
Raised $67,000,000.00 from SV Health Investors, Johnson & Johnson Innovation – JJDC, Novo Holdings, Red Tree Venture Capital and Canaan Partners.
Board Member
2021
Sardona Therapeutics is a preclinical biotechnology company building the leading platform to develop small molecule drugs that target RNA-binding proteins and provide patients with therapy-resistant cancers novel, and potentially best-in-class, treatment options.
Sardona Therapeutics is a Scaling New Peaks in Cancer Therapy.
Board Member
2020
A clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody
Trishula Therapeutics is a biotechnology company that focus on developing cancer medicines.
Co-Chair Board of Trustees - nonprofit
2020
Life Science Cares Bay Area is a platform for life science companies and staff to give back – time, talent or treasure. Life Science Cares is a collective effort of the life science industry to help address the impact of poverty on our neighbors in the greater Bay Area. Life Science Cares started in Boston in 2017 and expanded to Philadelphia in 2019, San Diego in 2020 and the Bay Area in 2021. Through uniting the human and financial resources of life science companies and industry leaders, we support nonprofit organizations that do the best work in fighting poverty and providing educational opportunity in our community. We work with organizations doing work in the areas of basic human survival (hunger, homelessness, domestic abuse, crime prevention, etc.), education (STEM education, college preparation and college success, educational enrichment and inspiration, etc.) and sustainability (job creation, job training, mentoring, and economic development.)
Member
2021
We're on a mission to accelerate the success of female founders and funders to build a more prosperous, equitable future. All Raise is on a mission to accelerate the success of female and non-binary founders and funders to build a more prosperous, equitable future. Born out of a grassroots movement in 2017, our programs arm women with access, guidance, and support to advance their professional growth. When the architects of tomorrow better reflect the world, our world is better served.
All Raise is a nonprofit on a mission to accelerate the success of female founders and funders to build a more prosperous equitable future.
Raised $15,000,000.00 from Silicon Valley Bank, Sequoia Capital, Pivotal Ventures, Bill & Melinda Gates Foundation, Reid Hoffman Foundation, Silicon Valley Bank and Pivotal Ventures.